CVS/pharmacy announced the launch of multiple efforts to fight prescription drug abuse across the country, including the availability of naloxone without a prescription in 12 additional states.
CVS/pharmacy has increased the availability of naloxone, an opioid overdose reversal agent, in several states. Naloxone is now accessible at CVS/pharmacy without a prescription in 12 new states: Arkansas, California, Minnesota, Mississippi, Montana, New Jersey, North Dakota, Pennsylvania, South Carolina, Tennessee, Utah and Wisconsin. CVS/pharmacy in Rhode Island and Massachusetts already allowed availability of naloxone without a prescription. The Company is also reviewing opportunities to expand its availability in other states. Further, CVS Health is participating in a research project with Boston Medical Center and Rhode Island Hospital to support a demonstration project of pharmacy-based naloxone rescue kits to help decrease opioid addiction and deaths from overdose.
CVS/pharmacy also announced the renewal of its Medication Disposal for Safer Communities Program, which has teamed up with the Partnership for Drug-Free Kids to donate drug collection units to police departments to help the safe disposal of unwanted medications, including controlled substances.
Additional CVS/pharmacy initiatives to fight prescription drug abuse include:
- Availability of postage-paid Environmental Return System envelopes at all of its pharmacies with which customers can send their unwanted medications for secure and environmentally-safe disposal.
- Identification of physicians who exhibit extreme patterns of prescribing high risk drugs such as pain medications and suspension of dispensing their controlled substance prescriptions.
- Advocating at the federal and state levels to implement policy changes to curb prescription drug abuse, such as mandatory electronic prescribing of controlled substances and improved prescription drug monitoring programs.
For more information visit CVSHealth.com.